BB Biotech AG

Research BB Biotech AG (BION.SW) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

About BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Related stock research

Switzerland stocks Switzerland Healthcare stocks A-Z stock index

Other Healthcare stocks

AC Immune SA (ACIU) Addex Therapeutics Ltd (ADXN) Bachem Holding AG (BANB) Bioversys AG (BIOV) Basilea Pharmaceutica AG (BSLN) CRISPR Therapeutics AG (CRSP) Idorsia Ltd (IDIA) MoonLake Immunotherapeutics - Class A (MLTX) MindMaze Therapeutics Holding SA (MMTX.SW) Molecular Partners AG (MOLN) NLS Pharmaceutics Ltd (NCEL) Oculis Holding AG (OCS)

Frequently asked questions

What does BB Biotech AG do?

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.